Interaction of green tea catechins with renal organic cation transporter 2

References

• Abe K, Suzuki T, Ijiri M, et al. (2007). The anti-fibrotic effect of green tea with a high catechin content in the galactosamine-injured rat liver. Biomed Res 28:43–8
   PubMed Web of Science ®Google Scholar
• Asavapanumas N, Kittayaruksakul S, Meetam P, et al. (2012). Fenofibrate down-regulates renal OCT2-mediated organic cation transport via PPARα-independent pathways. Drug Metab Pharmacokinet 27:513–9
   PubMed Web of Science ®Google Scholar
• Cabrera C, Artacho R, Giménez R. (2006). Beneficial effects of green tea – a review. J Am Coll Nutr 25:79–99
   PubMed Web of Science ®Google Scholar
• Chaiwong S, Theppakorn T. (2010). Bioactive compounds and antioxidant capacity of pink pummel (Citrus grandis (L.) Osbeck) CV. “Thong Dee” in Thailand. J Int Soc Southeast Asian Agri Sci 16:10–6
   Google Scholar
• Choi MK, Song IS. (2008). Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences. Drug Metab Pharmacokinet 23:243–53
   PubMed Web of Science ®Google Scholar
• Chow HH, Hakim IA. (2011). Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res 64:105–12
   PubMed Web of Science ®Google Scholar
• Chu KO, Wang CC, Chu CY, et al. (2006). Pharmacokinetic studies of green tea catechins in maternal plasma and fetuses in rats. J Pharm Sci 95:1372–81
   PubMed Web of Science ®Google Scholar
• Chung JH, Choi DH, Choi JS. (2009). Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos 30:90–3
   PubMed Web of Science ®Google Scholar
• Ciarimboli G, Schlatter E. (2005). Regulation of organic cation transport. Pflugers Arch 449:423–41
   PubMed Web of Science ®Google Scholar
• Eisenberg DM, Davis RB, Ettner SL, et al. (1998). Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–75
   PubMed Web of Science ®Google Scholar
• Eisner C, Faulhaber-Walter R, Wang Y, et al. (2010). Major contribution of tubular secretion to creatinine clearance in mice. Kidney Int 77:519–26
   PubMed Web of Science ®Google Scholar
• Fuchikami H, Satoh H, Tsujimoto M, et al. (2006). Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 34:577–82
   PubMed Web of Science ®Google Scholar
• Henning SM, Niu Y, Lee NH, et al. (2004). Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr 80:1558–64
   PubMed Web of Science ®Google Scholar
• Hermann R, von Richter O. (2012). Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med 78:1458–77
   PubMed Web of Science ®Google Scholar
• Hodgson AB, Randell RK, Boon N, et al. (2013). Metabolic response to green tea extract during rest and moderate-intensity exercise. J Nutr Biochem 24:325–34
   PubMed Web of Science ®Google Scholar
• Hosoyamada M, Obinata M, Suzuki M, Endou H. (1996). Cisplatin-induced toxicity in immortalized renal cell lines established from transgenic mice harboring temperature sensitive SV40 large T-antigen gene. Arch Toxicol 70:284–92
   PubMed Web of Science ®Google Scholar
• Ichinose T, Nomura S, Someya Y, et al. (2011). Effect of endurance training supplemented with green tea extract on substrate metabolism during exercise in humans. Scand J Med Sci Sports 21:598–605
   PubMed Web of Science ®Google Scholar
• International Organization for Standardization. (2005). Determination of substances characteristic of green and black tea: Part 2: Content of catechins in green tea: method using high performance liquid chromatography, Switzerland. Ref. no. ISO 14502-2:2005/Cor 1:2006
   Google Scholar
• Inui K, Masuda IS, Saito H. (2000). Cellular and molecular aspects of drug transport in the kidney. Kidney Int 58:944–58
   PubMed Web of Science ®Google Scholar
• Jodoin J, Demeule M, Beliveau R. (2002). Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta 1542:149–59
   PubMed Web of Science ®Google Scholar
• Karbach U, Kricke J, Meyer-Wentrup F, et al. (2000). Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am J Physiol Renal Physiol 279:F679–87
   PubMed Web of Science ®Google Scholar
• Koepsell H, Lips K, Volk C. (2007). Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227–51
   PubMed Web of Science ®Google Scholar
• Kwon M, Choi YA, Choi MK, Song IS. (2014). Organic cation transporter-mediated drug-drug interaction potential between berberine and metformin. Arch Pharm Res 38:849–56
   PubMed Web of Science ®Google Scholar
• Lavretsky H. (2009). Complementary and alternative medicine use for treatment and prevention of late-life mood and cognitive disorders. Aging Health 5:61–78
   PubMedGoogle Scholar
• Lepist EI, Ray AS. (2012). Renal drug-drug interactions: what we have learned and where we are going. Expert Opin Drug Metab Toxicol 8:433–48
   PubMed Web of Science ®Google Scholar
• Liang G, Tang A, Lin X, et al. (2010). Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 37:111–23
   PubMed Web of Science ®Google Scholar
• Lin LC, Wang MN, Tsai TH. (2008). Food-drug interaction of (-)-epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38.” Chem Biol Interact 174:177–82
   PubMed Web of Science ®Google Scholar
• Lin YS, Tsai YJ, Tsay JS, Lin JK. (2003). Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem 51:1864–73
   PubMed Web of Science ®Google Scholar
• Mata-Bilbao Mde L, Andres-Lacueva C, Roura E, et al. (2008). Absorption and pharmacokinetics of green tea catechins in beagles. Br J Nutr 100:496–502
   PubMed Web of Science ®Google Scholar
• Misaka S, Miyazaki N, Fukushima T, et al. (2013). Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats. Phytomedicine 20:1247–50
   PubMed Web of Science ®Google Scholar
• Monteiro R, Calhau C, Martel F, et al. (2005). Modulation of MPP+ uptake by tea and some of its components in Caco-2 cells. Naunyn Schmiedebergs Arch Pharmacol 372:147–52
   PubMed Web of Science ®Google Scholar
• Motohashi H, Inui K. (2013). Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney. AAPS J 15:581–8
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Ariyoshi N, Kotani A, et al. (2004). Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab Pharmacokinet 19:280–9
   PubMedGoogle Scholar
• Pritchard JB. (1990). Rat renal cortical slices demonstrate p-aminohippurate/glutarate exchange and sodium/glutarate coupled p-aminohippurate transport. J Pharmacol Exp Ther 255:969–75
   PubMed Web of Science ®Google Scholar
• Qin YJ, Chu KO, Yip YW, et al. (2014). Green tea extract treatment alleviates ocular inflammation in a rat model of endotoxin-induced uveitis. PLoS One 9:e103995
   PubMed Web of Science ®Google Scholar
• Roth M, Timmermann BN, Hagenbuch B. (2011). Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos 39:920–6
   PubMed Web of Science ®Google Scholar
• Shirasaka Y, Suzuki K, Nakanishi T, Tamai I. (2010). Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide. Pharm Res 27:2141–9
   PubMed Web of Science ®Google Scholar
• Shu Y. (2011). Research progress in the organic cation transporters. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36:913–26
   PubMedGoogle Scholar
• Skalli S, Soulaymani Bencheikh R. (2012). Safety monitoring of herb-drug interactions: a component of pharmacovigilance. Drug Saf 35:785–91
   PubMed Web of Science ®Google Scholar
• Somsak V, Jaihan U, Srichairatanakool S, Uthaipibull C. (2013). Protection of renal function by green tea extract during Plasmodium berghei infection. Parasitol Int 62:548–51
   PubMed Web of Science ®Google Scholar
• Sugawara-Yokoo M, Urakami Y, Koyama H, et al. (2000). Differential localization of organic cation transporters rOCT1 and rOCT2 in the basolateral membrane of rat kidney proximal tubules. Histochem Cell Biol 114:175–80
   PubMed Web of Science ®Google Scholar
• Takeda M, Khamdang S, Narikawa S, et al. (2000). Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther 300:918–24
   Web of Science ®Google Scholar
• Toolsee NA, Aruoma OI, Gunness TK, et al. (2013). Effectiveness of green tea in a randomized human cohort: relevance to diabetes and its complications. Biomed Res Int 2013:412379
   PubMed Web of Science ®Google Scholar
• Urakami Y, Kimura N, Okuda M, Inui K. (2004). Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney. Pharm Res 21:976–81
   PubMed Web of Science ®Google Scholar
• Vallon V, Eraly SA, Rao SR. (2012). A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. Am J Physiol Renal Physiol 302:F1293–9
   PubMed Web of Science ®Google Scholar
• Wang P, Henning SM, Heber D. (2010). Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One 5:e10202
   PubMed Web of Science ®Google Scholar
• Wright SH, Dantzler WH. (2004). Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84:987–1049
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Noh JS, Park CH. (2012). Green tea polyphenols for the protection against renal damage caused by oxidative stress. Evid Based Complement Alternat Med 2012:845917
   PubMedGoogle Scholar
• Zhang L, Brett CM, Giacomini KM. (1998). Role of organic cation transporters in drug absorption and elimination. Annu Rev Pharmacol Toxicol 38:431–60
   PubMed Web of Science ®Google Scholar
• Zhang L, Reynolds KS, Zhao P, Huang SM. (2010). Drug interactions evaluation: an integrated part of risk assessment of therapeutics. Toxicol Appl Pharmacol 243:134–45
   PubMed Web of Science ®Google Scholar
• Zolk O, Solbach TF, König J, Fromm MF. (2009). Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2). Naunyn Schmiedebergs Arch Pharmacol 379:337–48
   PubMed Web of Science ®Google Scholar